Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction

ConditionBradycardia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorÓscar Cano Pérez

About this trial

Intraventricular conduction delay alone or in combination with AV conduction delay is associated with a dyssynchronous activation of the ventricles and may result in LV function impairment.

Conduction system pacing can restore physiologic ventricular activation in the presence of intraventricular and atrioventricular conduction delays.

Patients with intraventricular conduction delay alone or in combination with AV conduction delay who have a permanent pacemaker indication due to intermittent bradycardia and have predominantly intact AV conduction may benefit from continuous CSP.

Eligibility criteria

Qualifiers

age > 18 years

Any indication for cardiac pacing with an expected VP burden ≤ 10% after 1- month run-in period

Baseline wide QRS (≥150 ms) with normal PR or QRS ≥ 130 ms + PR≥230 ms

LVEF≥50%

Disqualifiers

Pregnant woman

Permanent or long-lasting atrial fibrillation

Previous PM/ICD

Unstable angina, acute Myocardial Infarction (MI), Coronary Artery Bypass Graft (CABG), Percutaneous Coronary Angioplasty (PCI), surgical valve repair or replacement within 90 days prior enrollment

Trial design

Treatments tested in this trial

  • Pacemaker implant

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

3
Hospital Universitario Virgen de las Nieves18014, GranadaAndalusia, Spain
Hospital Clínico Universitario Lozano Blesa50009, ZaragozaAragon, Spain
Hospital Universitari i Politècnic La Fe46026, ValenciaValencia, Spain

Sponsors and collaborators

Óscar Cano Pérez

Lead sponsor

Spanish Society of Cardiology

Sponsor institution